Q/C Technologies, Inc. (QCLS): Total Assets
$41.17M
As of 2025-12-31
$22.87M
As of 2026-06-30
+32.9%
3-year compound annual growth
n/m
5-year compound annual growth
+17.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.17M | +92.2% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $21.42M | +19.9% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $17.86M | +1.8% | 2025-04-11, Balance as of period end |
| 2022-12-31 | $17.54M | -29.3% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $24.81M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | $676.7K | -93.8% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $10.88M | +39.4% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $7.81M | -16.4% | 2020-03-25, Balance as of period end |
| 2017-12-31 | $9.34M | +83.6% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $5.09M | -38.5% | 2018-07-13, Balance as of period end |
| 2015-12-31 | $8.27M | -50.3% | 2017-04-11, Balance as of period end |
| 2014-12-31 | $16.65M | +174.1% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $6.08M | n/a | 2015-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Q/C Technologies, Inc. (QCLS) | 2025-12-31 | $41.17M | +92.2% |
| Achieve Life Sciences, Inc. (ACHV) | 2025-12-31 | $41.79M | +8.2% |
| Immucell Corp (ICCC) | 2025-12-31 | $42.53M | -5.7% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.24M | +59.8% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $25.76M | -26.6% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $103.58M | -12.8% |
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | $7.77M | -26.8% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $6.90M | -26.6% |
| Biomerica Inc (BMRA) | 2026-05-31 | $6.76M | +13.7% |
Compare QCLS, ACHV, ICCC, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗